| Literature DB >> 25854856 |
Hideaki Furuta1, Shintaro Mori2, Yasuo Yoshihashi1, Etsuo Yonemochi3, Hidehiro Uekusa2, Kiyohiko Sugano4, Katsuhide Terada1.
Abstract
Pranlukast (PRS) is a leukotriene receptor antagonist for the treatment of bronchial asthma. In this study, six new solvates and one new cocrystal of PRS were characterized by PXRD, TG-DTA, DSC, vapor sorption analysis and the dissolution test. In addition, the crystal structures were determined by single crystal X-ray structure analysis. PRS was found to be a rare example of a promiscuous multicomponent crystal former. The crystal packing patterns of these crystals can be categorized into the sheet-like and channel-like patterns. The ethanol solvate (PRS/ethanol) and urea cocrystal (PRS/urea) were more stable than the others under humid conditions. PRS/ethanol showed an improved dissolution profile compared to PRS HH and PRS/urea.Entities:
Keywords: Crystal structure; Dissolution; Pranlukast; Pseudo-polymorph; Vapor sorption
Mesh:
Substances:
Year: 2015 PMID: 25854856 DOI: 10.1016/j.jpba.2015.03.008
Source DB: PubMed Journal: J Pharm Biomed Anal ISSN: 0731-7085 Impact factor: 3.935